News Focus
News Focus
icon url

zipjet

12/11/07 8:17 AM

#2642 RE: xrymd #2640

xrymd,

I largely agree with you.

This will be a safer buy after funding is certain.

But the decline has priced in some of the risk. And rather than the decline continuing the stock has been stable and started rising. At the same time we see filings of a large owner that is adding here. They are adding DESPITE the obvious funding needs. The clear inference is that they are not put off by the funding issue.

Seems to me that it is time to take a partial position in RPRX with the knowledge that if the stock sells off further on funding that it is time to complete the position.

zip

Some personal comments. Thomas has had rational comments to make but his attacks on Nerf have been distracting. And now Nerf has blown up at Thomas detracting from substance. Telling those who are not perma-bulls to stop posting is not helpful. JMHO

PS - Nerf is a great guy who is more emotional in his expressions than some others. Too bad he can't bottle some of that and give it to me. :-)
icon url

Nerf

12/11/07 8:56 AM

#2643 RE: xrymd #2640

Youre correct about the emotion. I have been ruthlessly attacked by one or two people for my views and sometimes I throw caution to the wind and speak my mind. Unlike zipjet who keeps an iron lock on his emotions and posts with logical, completely on topic, messges known for their brevity and laser like focus, I don't have that gift. Sometimes I gotta rant. I wish I could be more level headed but once in a while it gets the better of me.

As for RPRX, this is the last dip, IMO. They're not going to be around next year at this time, unless something drastic happens, like a complete turnaround of efficacy on Proellex. Small companies with drugs that eventually work, rarely make it to an NDA filing, most are gone during or just after interim PIII pivotals unless they just aren't interested in being bought, at all.
icon url

corpstrat

12/11/07 10:17 AM

#2646 RE: xrymd #2640

<<most of what Thomas states appears to be true.>>

Thomas said two things in that post, neither of which was true.

1. He said nobody implied the FDA might reject the IND. I corrected that a few minutes ago.

2. He said the anemia program is now badly delayed and the IND is months away. But Repros says the anemia trial is on track to begin Q1 2008. So the Nov 30 meeting did not represent months of delay and the IND is not months away.

What is left in what Thomas stated that appears to you to be true?